Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPPH with PDT vs Surgery for Oral Cavity Cancer
NCT03090412Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Mar 2018
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hpph in squamous cell carcinoma of the oral cavity (OSCC) (2 arms), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoint: Rate of Tumor Response at 24 months. Started Mar 2018; status: terminated.
02
Drugs
hpph
03
Conditions
squamous cell carcinoma of the oral cavity (OSCC)
Beyond the preview
Go deeper on NCT03090412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090412.